SCO1 is a ubiquitously expressed, mitochondrial protein with essential roles in cytochrome c oxidase (COX) assembly and the regulation of copper homeostasis. SCO1 patients present with severe forms of early onset disease, and ultimately succumb from liver, heart or brain failure. However, the inherent susceptibility of these tissues to SCO1 mutations and the clinical heterogeneity observed across SCO1 pedigrees remain poorly understood phenomena. To further address this issue, we generated Sco1 hrt/hrt and Sco1 stm/stm mice in which Sco1 was specifically deleted in heart and striated muscle, respectively.
Lethality was observed in both models due to a combined COX and copper deficiency that resulted in a dilated cardiomyopathy. Left ventricular dilation and loss of heart function was preceded by a temporal decrease in COX activity and copper levels in the longer-lived Sco1 stm/stm mice. Interestingly, the reduction in copper content of Sco1 stm/stm cardiomyocytes was due to the mislocalisation of CTR1, the high affinity transporter that imports copper into the cell. CTR1 was similarly mislocalized to the cytosol in the heart of knockin mice carrying a homozygous G115S substitution in Sco1, which in humans causes a hypertrophic cardiomyopathy. Our current findings in the heart are in marked contrast to our prior observations in the liver, where Sco1 deletion results in a near complete absence of CTR1 protein. These data collectively argue that mutations perturbing SCO1 function have tissue-specific consequences for the machinery that ultimately governs copper homeostasis, and further establish the importance of aberrant mitochondrial signaling to the etiology of copper handling disorders.
Introduction
Copper is an essential micronutrient that can rapidly cycle between two redox states, Cu þ and Cu 2þ , thereby facilitating electron transfer. This property has been co-opted by a number of proteins which use copper as a cofactor to catalyze biochemical reactions critical to respiration, free radical detoxification, iron homeostasis, and neurotransmitter and collagen biosynthesis (1, 2) . Copper is also extremely toxic in excess because it can destabilize ironsulphur clusters (3, 4) and potentiate the generation of highly damaging free radicals (5, 6) . Conserved mechanisms therefore evolved to mitigate its toxic potential, and act in concert to regulate total and bioavailable copper stores such that the cell contains negligible amounts of the free metal ion (7) . Genetic lesions or environmental insults that impair these copper handling mechanisms perturb copper homeostasis, and underlie a number of severe forms of human disease (8) .
In mammals, copper enters the cell through the essential protein CTR1, the only known high-affinity copper importer (9, 10) . CTR1 functions as a homotrimer to facilitate copper translocation across the plasma membrane (11) . Copper is then transferred to evolutionarily conserved, soluble chaperones that deliver it to various subcellular compartments (12) (13) (14) (15) (16) . CTR1 abundance and localisation are tightly controlled to regulate the rate of copper import and, by extension, cellular copper homeostasis. Under conditions of copper excess, CTR1 can be internalized from the plasma membrane into endosomes (17) , a mechanism that is thought to protect the cell from copper toxicity (18) . Endosomally-localized CTR1 can then be targeted for degradation by the proteasome, or recycled back to the plasma membrane (19) . However, the universality of this regulatory mechanism has been debated, given that CTR1 localisation is not always altered in response to increased copper concentrations (20) . The P-type ATPases ATP7A and ATP7B normally reside in the trans-Golgi network where they promote the metallation of secreted cuproproteins (21) (22) (23) . However, both proteins also undergo regulated trafficking to the cell periphery where they facilitate copper export (24, 25) . Pathogenic mutations in ATP7A and ATP7B severely perturb protein function and cause Menkes and Wilson disease, respectively (26, 27) .
There is a growing appreciation for the influence of mitochondria on how the cell senses its copper status and prioritizes its copper stores to maintain homeostasis (28) . Mitochondria contain two enzymes that depend on copper for their activity; cytochrome c oxidase (COX) and a small, but physiologically significant fraction of copper-zinc superoxide dismutase (SOD1). COX contains two copper prosthetic groups (Cu A , Cu B ) that are matured within the intermembrane space of the mitochondrion in biochemical reactions that require a surprisingly large number of accessory proteins termed COX assembly factors. Pathogenic mutations in genes encoding three of these factors, COA6, SCO1 and SCO2, impair copper delivery to the Cu A site of COX and result in a severe, isolated COX deficiency that underlies a number of early onset forms of fatal human disease (29) (30) (31) . SCO1 and SCO2 are paralogs with complementary but non-overlapping functions in this pathway that rely on the ability of each protein to bind copper (32, 33) . SCO gene mutations also impair the function of a redox-dependent, mitochondrial signaling pathway that is integral to the regulation of cellular copper homeostasis, and affected tissues in SCO1 and SCO2 patients are both COX and copper deficient (34) (35) (36) .
Three pedigrees with pathogenic mutations in SCO1 have been described to date, each with a unique clinical phenotype and course of disease that selectively affects liver (30; P174L/ R149X), heart (36; G132S/G132S) and/or brain (37; M294V/Y93X) function. How different mutations in a ubiquitously expressed gene produce such striking clinical heterogeneity remains an enduring mystery. Affected SCO1 patient tissues are severely copper deficient, and the copper deficiency in SCO1 and SCO2 patient fibroblasts is driven in large part by a disproportionate rate of copper efflux from the cell (34) . In contrast, loss of SCO1 function in the liver of a mouse model of the human disease results in a severe copper deficiency that is caused by a significant reduction in CTR1 abundance, and therefore copper uptake (38) . These observations suggest that differences may exist across cell types in how SCO1-dependent mitochondrial signaling is integrated into the regulatory framework that controls copper homeostasis. To determine if this aspect of SCO1 function does in fact differ across tissues, we investigated its importance to copper homeostasis in the developing and adult heart using two relevant mouse models. We found that deletion of Sco1 in both a heart and a striated muscle-specific knockout mouse was lethal, and that Sco1 null hearts were both COX and copper deficient. However, unlike our previous findings in the Sco1 null liver (38) , the cardiac copper deficiency was caused by CTR1 mislocalisation rather than a reduction in its abundance. Disproportionate internalization of CTR1 in the absence of any changes in its steady-state levels was also observed in a Sco1 G115S/G115S knockin mouse, an animal model of the human disease that results in an early onset, fatal cardiomyopathy in one of the three SCO1 pedigrees (36) . These data collectively support the concept that copper homeostasis is regulated by redox-dependent signaling through SCO1 in a tissue-specific manner.
Results
Generation of a heart-specific Sco1 knockout mouse
The SCO1 patient homozygous for the G132S mutation exhibited defects in cardiac physiology and presented with a lethal, neonatal cardiomyopathy (36) . To better understand the mechanisms underlying the tissue-specific pathology and progression of this disease, we generated a transgenic mouse model in which Sco1 was specifically deleted in the heart. Briefly, mice containing a pair of loxP sites flanking the second exon of the Sco1 gene (Sco1 Fig. S1A ), none survived beyond two days of age (Fig. 1A) . PCR amplification of the Sco1 locus in a number of somatic tissues confirmed that Cre-mediated excision events were restricted to the myocardium (Supplementary Material, Fig. S1B) , and Western blot analysis demonstrated that the hearts of Sco1 hrt/hrt mice had very low levels of SCO1 protein as early as embryonic day 15 (E15) (Fig. 1B) .
Sco1
hrt/hrt mice have a dilated cardiomyopathy owing to a severe, isolated COX deficiency
To further investigate the underlying basis of lethality in these animals, we first examined the Sco1 hrt/hrt heart histologically.
Hematoxylin and eosin staining revealed an enlarged left ventricle, indicative of a dilated cardiomyopathy (Fig. 1C) . Negative Masson's trichrome staining (Fig. 1D) suggests that the ventricular dilation occurred in the absence of significant fibrosis. Sco1 hrt/hrt hearts also exhibited a severe COX deficiency when compared with wild-type hearts (Fig. 1E , Supplementary Material, Fig. S1C ). The COX deficiency was not accompanied by a change in the activity of citrate synthase (Fig. 1E) or the abundance of other OXPHOS complexes (Fig. 1F, Supplementary Material, Fig. S1C ), suggesting that mitochondrial content remained unchanged in hearts that lack SCO1 expression. A combined COX and copper deficiency is observed in affected SCO1 patient tissues, and is a hallmark of the associated disease and its progression (36, 38) . Accordingly, the Sco1 hrt/hrt heart had a slight, but statistically significant reduction in total copper content when compared with the wild-type heart (Fig. 1G) , as well as a decrease in the total activity of superoxide (53) were used as a reference control to identify the glycosylated (arrow) and truncated (asterisk) forms of CTR1. Mouse embryonic fibroblasts treated with scrambled (Ccs wt ) or Ccs siRNA (Ccs siRNA ) were also included as controls to identify the authentic species of CCS protein, which is denoted by the unfilled arrow. GAPDH was used as a loading control.
dismutase (SOD) (Fig. 1E ) that was directly attributable to a reduction in the activity of the copper-dependent SOD1 form of the enzyme (Supplementary Material, Fig. S1D ). Immunoblot analysis demonstrated that the mild copper deficiency in Sco1 hrt/hrt hearts was not caused by changes in the total abundance of the copper import protein CTR1 or the copper export protein ATP7A (Fig. 1H ). While total copper levels and CTR1 abundance were both significantly lower in the liver of Sco1 Striated-muscle specific Sco1 knockout mice also develop a severe, dilated cardiomyopathy
The sudden perinatal lethality of the Sco1 hrt/hrt mice precluded any meaningful investigation of disease progression owing to the loss of SCO1 function in the heart of this animal model. We therefore used a different Cre driver line in conjunction with the breeding strategy described above to generate striated muscle-specific Sco1 knockout mice, hereafter referred to as Sco1 stm/stm mice. Dysfunction in Sco1 stm/stm hearts is due to a combined COX and copper deficiency that worsens with age
To further investigate the underlying cause of the ventricular dilation in Sco1 stm/stm mice, we characterized P90 hearts at a biochemical, molecular and elemental level. Sco1 stm/stm hearts had a significant reduction in COX activity and COX IV protein levels when compared with the hearts of wild-type littermates ( Fig. 3A and D, Supplementary Material, Fig. S2C ). Sco1 stm/stm hearts also exhibited a severe defect in total SOD activity (Fig. 3A) that was specific to the copper-dependent SOD1 form of the enzyme (Supplementary Material, Fig. S2D ). Like Sco1 hrt/hrt mice, the COX deficiency in Sco1 stm/stm hearts was not caused by changes in mitochondrial content or remodelling, as the activity of citrate synthase (Fig. 3A) and the abundance of other OXPHOS complexes (Fig. 3B ) remained unchanged. Sco1 stm/stm hearts had significantly lower total copper levels than wild-type hearts, in the absence of changes in the total abundance of iron and zinc (Fig. 3C) . None of the other somatic tissues of Sco1 stm/stm mice we investigated exhibited altered copper, iron or zinc levels (Supplementary Material, Fig. S2E ). Immunoblot analysis revealed that the severe copper deficiency in the P90 Sco1 stm/stm heart was not attributable to a reduction in CTR1 abundance (Fig. 3D ).
To more thoroughly characterize disease progression and the underlying cause of the copper deficiency in the Sco1 stm/stm heart, we next investigated wild-type and Sco1 stm/ stm hearts at three earlier time points. At P18, Sco1 stm/stm hearts exhibited a mild COX deficiency in the absence of a detectable change in total copper content ( Fig. 4A and B) . Sco1 stm/stm hearts were both COX and copper deficient at P30, with the combined deficiency worsening significantly by P60 ( Fig. 4A  and B ). Immunoblot analysis of wild-type and Sco1 stm/stm hearts demonstrated that there was no difference in the total abundance of ATP7A (Fig. 4C) , suggesting that the observed increase in ATP7A at P90 (Fig. 3D ) occurs well after the initial onset of the copper deficiency. The abundance of CCS, a known biomarker of cytoplasmic copper status (39) , was also unchanged. Interestingly, steady-state levels of CTR1 were elevated in response to Sco1 deletion, even at P18 when total cardiac copper content is comparable across genotypes ( Fig. 4B and C). These data collectively suggest that the copper deficiency in Sco1 stm/stm hearts is caused by loss of CTR1 copper import activity rather than its degradation.
Copper deficiency in Sco1 stm/stm and Sco1
G115S/G115S
knockin hearts is caused by mislocalisation of CTR1 to endosomes
We directly addressed the possibility that the cellular CTR1 pool was inappropriately distributed due to loss of SCO1 function by analysing wild-type and Sco1 stm/stm hearts from P60 animals by indirect immunofluorescence. We found that in the wild-type heart CTR1 was primarily localized to the plasma membrane, with intense fluorescence at the intercalated discs, a pattern that was coincident with the plasma membrane marker protein Na þ /K þ ATPase (Fig. 5) . In contrast, CTR1 immunofluorescence was more diffuse in its distribution and less coincident with the Na þ /K þ ATPase in the Sco1 stm/stm heart (Fig. 5) .
To compare and contrast the tissue-specific knockout with the human condition, we created a homozygous Sco1 G115S/G115S knockin mouse to model the SCO1 patient who presented neonatally with a fatal hypertrophic cardiomyopathy (36) . Sco1 G115S/ G115S hearts exhibited a severe, combined COX and copper deficiency, like the knockout mouse model (Fig. 6A and B) . The copper deficiency was not attributable to changes in the steadystate levels of CTR1 or ATP7A, and was not accompanied by changes in CCS abundance (Fig. 6B) . Further mirroring the Sco1 stm/stm heart, CTR1 was predominantly observed within the cytoplasm of the Sco1 G115S/G115S heart, rather than at the plasma membrane and intercalated disks (Fig. 6C) . These data strongly suggest that perturbation of cardiac SCO1 function causes a copper deficiency by impairing CTR1 trafficking to, or maintenance at, the plasma membrane.To distinguish between these two possibilities, we co-stained wildtype and Sco1 stm/stm hearts from P60 animals with antibodies raised against CTR1 and Rab5, an early endosomal marker. We found that internalized CTR1 convincingly co-localized with Rab5 in the Sco1 stm/stm heart (Supplementary Material, Fig. S3A ).
However, follow-up imaging experiments failed to detect significant co-localization of CTR1 with either EEA1, a Rab5 effector and early endosomal marker, or LAMP1, a late endosomal/lysosomal marker (Supplementary Material, Fig. S3B ). These data argue that loss of SCO1 function in the heart leads to CTR1 endocytosis from the plasma membrane.
Discussion
One of the puzzling hallmarks of disease in SCO1 patients is the tissue-specific clinical presentation and, in particular, the differential susceptibility of the liver, brain or heart among SCO1
pedigrees (30, 36, 37) . SCO1 is an essential, ubiquitously expressed protein whose function couples the metallation of the Cu A site of COX to the regulation of cellular copper homeostasis (28, 34, 36, 40) . How mitochondrial signaling in individual tissues is integrated into the regulatory framework that controls copper homeostasis remains unclear. To further explore this issue, and to build on our earlier work on a Sco1 mouse model of the human disease caused by liver failure (38), we generated two mouse models that lacked Sco1 expression in the heart. In both models, deletion of Sco1 was ultimately lethal, thus demonstrating the importance of SCO1 function to the developing and adult myocardium. A dilated cardiomyopathy owing to a combined COX and copper deficiency was manifest in both mouse models. SCO1 abundance was exceedingly low in the hearts of Sco1 hrt/hrt mice as early as E15, and continued to drop postnatally. In contrast, SCO1 was readily detectable in the hearts of Sco1 stm/stm mice up to P3. It is therefore likely that in this model there was sufficient residual SCO1 to support the development and rapid growth of the heart during this early perinatal window. Consistent with this idea, P18 Sco1 stm/stm hearts only exhibited a mild COX deficiency relative to wild-type littermates. We cannot, however, discount the possibility that changes in the skeletal muscle also contributed to the longer lifespan in Sco1 stm/stm mice, as a previous study elegantly demonstrated that simultaneous deletion of an unrelated mitochondrial gene in the heart and skeletal muscle contributed to a sparing effect on the heart itself (41).
Hearts from both Sco1 hrt/hrt and Sco1 stm/stm mice were comprised of enlarged and vacuolated cardiomyocytes, and Sco1 stm/stm hearts exhibited profound fibrosis and changes in the expression of multiple markers for fetal cardiac remodeling, presumably owing to their longer lifespan. These data combined with the significant increase in heart to body weight ratio and the dilation of the left ventricle observed by echocardiography suggest a dilated cardiomyopathy with mild cardiac hypertrophy in the P90 Sco1 stm/stm heart.
Multiple lines of evidence strongly suggest that the primary factor for the copper deficiency in the Sco1 stm/stm and Sco1 G115S/ G115S hearts is the mislocalisation of CTR1. In the wild-type heart, CTR1 is localized primarily to the plasma membrane with particularly intense staining at the intercalated discs. These data corroborate the findings of an earlier study in the heart (42), and suggest that CTR1 facilitates copper transport between cardiomyocytes at these cell-cell junctions, similar to other ions and metabolites (43) (44) (45) . In contrast, CTR1 abundance at the intercalated disc was greatly attenuated in the Sco1 stm/stm heart, where the protein was primarily localized to punctate intracellular structures found within the cytosol. CTR1-positive intracellular structures co-localized significantly with Rab5, but not with EEA1 or LAMP1. There is emerging evidence of an alternative endocytic pathway where relatively long-lived, Rab5-positive early endosomes contain the effectors APPL1 and APPL2 rather than EEA1 (46, 47) . Though these endosomes can be discriminated from the canonical EEA1-positive, early endosomes and are known to play important roles in storage, trafficking and signal transduction, their biological properties remain largely unknown (46, 47) . Our results raise the intriguing possibility that CTR1 is internalized in APPL-positive vesicles, although future studies will be required to confirm that loss of cardiac SCO1 function promotes CTR1 internalization via this alternate pathway. Similar intracellular redistribution of the total CTR1 pool away from the plasma membrane and intercalated disks was also observed in a heart homozygous for the SCO1 G115S substitution, the same allelic variant that in humans results in a hypertrophic cardiomyopathy (36) . These data collectively argue that loss of SCO1 function in the heart causes a copper deficiency by impairing CTR1 localisation to the plasma membrane and therefore copper uptake into the cardiomyocyte. Yet another intriguing finding of the present study is that perturbing the function of SCO1 in cardiomyocytes has a fundamentally different effect on CTR1 than it does in other cell types. Deletion of Sco1 in both murine liver and embryonic fibroblasts promotes the degradation of CTR1, leading to a significant reduction in its steady-state levels (38) . In contrast, Sco1 stm/stm and Sco1 G115S/G115S hearts have wild-type CTR1 abundance but fail to maintain adequate levels of the protein at the plasma membrane and intercalated disks to support copper import as evidenced by cardiac copper deficiency in these animals. The glycine to serine substitution in both mouse (unpublished data) and human SCO1 (36,37) does not completely abolish protein function, and allows for a longer lifespan in the Sco1 G115S/G115S mice. Nonetheless, CTR1 is still mislocalized in the Sco1 G115S/G115S heart, arguing that the effects we observe on CTR1 in the Sco1 stm/stm heart are not simply a consequence of Sco1 ablation and the resultant reduction in COX activity. While we do not yet know why perturbing SCO1-dependent mitochondrial signaling has distinct effects on CTR1 in the heart and liver, it may reflect different copper requirements in these tissues. Indeed, tissue-specific deletion of Ctr1 in the heart is associated with rapid cardiac hypertrophy and lethality (48, 49) , suggesting a continuous need for CTR1-mediated copper uptake by cardiomyocytes and, by extension, little storage capacity. Therefore, it may be necessary in the heart to acutely regulate the localization rather than the steady-state levels of CTR1 in the face of Sco1 deletion, to allow for more rapid responses to intrinsic changes in copper demand or extrinsic fluctuations in plasma copper levels. In contrast, the liver is a copper storage organ with higher total copper concentrations than the heart (34,50,51).Thus, degradation of CTR1 rather than recycling in response to Sco1 deletion may reflect the relative abundance of copper in this organ or the existence of alternative pathways of copper acquisition. Consistent with this hypothesis, tissue-specific deletion of Ctr1 in the liver during the postnatal period is associated with very mild hepatic copper deficiency and normal longevity (52) . How the loss of SCO1 function alters CTR1 localization in the heart while promoting CTR1 degradation in the liver remains an open question. Differences in redox balance between these two organs may contribute to the observed tissue-specific consequences of perturbing SCO1-dependent mitochondrial signaling on CTR1 function. The severe COX deficiency in Sco1 null livers and hearts likely leads to oxidative stress. However, the metabolic poise and redox buffering capacity of each of these tissues is significantly different (53, 54) , and both of these factors may modulate the rate or nature of the signal that is transduced from the mitochondrion and sensed by other copper handling machinery. Signaling may also involve the release of one or more soluble, tissue-specific factors from the organelle that then acts to regulate CTR1 trafficking or degradation (28, 40) . Alternatively, loss of SCO1 function may affect signaling mediated by copper fluxes between mitochondria and the cytosol in a cell-type specific manner. Consistent with this idea, perturbing SCO1 function in the liver but not the heart alters the abundance of CCS (38) , the only known biomarker of cytosolic copper status (39) . The reduction in hepatic copper levels in our Sco1 hrt/hrt mouse model is an equally intriguing observation and points to crosstalk between the two tissues. Indeed, our findings mirror many aspects of those from an earlier study in which the high affinity copper importer Ctr1 was deleted in the heart using the same Cre driver line (55) . Because CTR1 is the only high affinity copper importer, we favour the idea that the COX-deficient Ctr1 hrt/hrt heart is signaling to the liver in an attempt to correct this metabolic defect. Kim et al. (55) in fact demonstrate that CCS abundance is very high in the Ctr1 hrt/hrt heart, suggesting that the organ is appropriately sensing a copper-deficient state in these animals. They then go on to show that there is a soluble factor in the plasma of Ctr1 hrt/hrt mice that drives hepatic mobilization of copper into the circulation by increasing the steady-state levels of ATP7A. Mobilization of hepatic copper stores is consistent with one of the known roles of the liver in early perinatal life, which is to distribute copper and other essential metal ions to peripheral tissues to support organogenesis, and in the Ctr1 hrt/hrt mouse is presumably occurring at a disproportionate rate in an attempt to rescue the failing and copper-deficient myocardium. In our Sco1 hrt/hrt mouse model, however, liver ATP7A abundance and plasma copper levels are normal, and none of the peripheral tissues we examined have increased copper levels. CCS abundance is also unchanged in the Sco1 hrt/hrt heart, leading us to speculate Immunofluorescence analysis of CTR1 localisation in P120 wild-type (top) and Sco1 G115S/G115S (bottom) hearts. Images were taken at 40X magnification, and the plasma membrane marker Na þ /K þ ATPase was used as a positive control. Scale bar represents 20 lm. Inset contains magnified image of selected region of interest (white box).
that deletion of Sco1 in the heart in this mouse model somehow signals a state of copper overload that is communicated to the liver and results in reduced CTR1 levels and increased excretion of copper in the bile. Our findings emphasize the essential role of SCO1 in the mitochondrial regulation of copper homeostasis in both the developing and adult myocardium. They also strongly suggest that tissue-specific factors impinge upon how organelle signaling is sensed and integrated into the regulatory framework that controls copper homeostasis. Studies to identify the mechanistic basis that underpins the modulation of SCO1-dependent mitochondrial signaling in different tissues are on-going.
Materials and Methods

Generation of Sco1 mouse models
Conditional Sco1 knockout models were generated by crossing Sco1 floxed mice (Sco1 flox/flox ) (38) with mice in which Cre recombinase expression is driven by the a-myosin heavy chain (The Jackson Laboratory, strain #018972) or the creatine kinase promoter (The Jackson Laboratory, strain #006475). Cre positive, F1 progeny were then backcrossed to Sco1 flox/flox animals to generate heart-specific (Sco1 hrt/hrt ) or striated musclespecific (Sco1 stm/stm ) Sco1 knockout mice. PCR genotyping of all animals in this breeding scheme was performed as previously described (38) . Sco1 G115S/wt knockin mice were generated fee-for-service at the Toronto Centre for Phenogenomics. Briefly, the guide RNA 5'-GCATTAGCAAGCCTTTACTA-3', a single-strand oligonucleotide repair template with a silent mutation to disrupt the protospacer adjacent motif sequence, and Cas9 mRNA were coinjected into C57BL/6NCrl zygotes. Resultant pups were screened by sequencing end-point PCR products to identify the point mutation, and bred to C57BL/6NCrl for germline transmission of the knockin allele. Sco1 G115S/wt knockin mice were then backcrossed to C57BL/6NCrl animals for 3 successive generations to reduce the likelihood of animals carrying second site, off target mutations. Sco1 G115S/wt knockin mice were intercrossed, and then bred with Sco1 G115S/G115S knockin mice to both maintain a breeding colony and generate experimental animals. Tail DNA was prepared with the KAPA Mouse Genotyping Kit (KAPA Biosystems, KK5621), and 2 ml of a 1: 1 dilution in water was used in a 10 ml real-time PCR reaction with PerfeCTa qPCR ToughMix (VWR, CA97065-966) on the Applied Biosystems
Step One Plus Real Time Thermocycler. The PCR reaction mix contained 500 nM of primers (F: TTAGAGCTGGAGAAACAACGG, R: GGCTCTCCATTGTGAGTTGTA) and 250 nM of probes (wild-type HEX probe, CA þ TT þ gþG þ gAA þ GCC and G115S knockin FAM probe, CA þ TT þ aþG þ cAA þ GþCCT) purchased from Integrated DNA Technologies, and was run for 40 cycles with an annealing temperature of 60 C. All animal-related experiments were approved by the Animal Ethics Review Board at the University of Saskatchewan (AUP #20100091).
Echocardiography
The procedure for the mouse echocardiogram is described in detail elsewhere (56) . In brief, cardiac function of wild-type and Sco1 stm/stm mice (n ¼ 4) was evaluated at P60 and P90 using a high resolution Vevo 2100 ultrasound system (VisualSonics, Toronto, ON, Canada) equipped with an MS550 transducer. Mice were anaesthetized using 3% isoflurane for 1-2 min, and then maintained at 1.5-2% isoflurane after losing the righting reflex. Mice were laid supine on a heated platform during echocardiography. Left ventricle internal diameter end systole (LVIDs) and diastole (LVIDd), fractional shortening and ejection fraction were measured from the standard LV short-axis M-mode view. The heart rate, electrocardiogram (ECG), respiratory rate and body temperature of the mouse were monitored throughout the experiment. 
Tissue preparation and immunohistochemistry
Native and denaturing electrophoresis
Tissues from cervically dislocated mice were harvested and frozen at À80 C. Blue native polyacrylamide gel electrophoresis (BN-PAGE) analyses were conducted as described in detail elsewhere (57) . Briefly, a piece of heart tissue was resuspended and gently homogenized in extraction buffer [20 
RT-PCR analysis
Total RNA was isolated from hearts and reverse transcribed into cDNA, as previously described (38) . PCR reactions contained equal amounts of cDNA and unique primer sets to generate the following amplicons; ANP (F: GCTTCCAGGCCATATTGGAG, R: GGGGGCATGACCTCATCTT), BNP (F: GAGGTCACTCCTATCCTC TGG, R: GCCATTTCCTCCGACTTTTCTC), a-SA (F: CCCAAAGC TAACCGGGAGAAG, R: CCAGAATCCAACACGATGCC), SERCA2 (F: TGGAACAACCCGGTAAAGAGT, R: CACCAGGGGCATAATGAGC AG), MT1 (F: GTCCTCTAAGCGTCACCAC, R: GAGCAGTTGGGG TCCATTC) and GAPDH (F: ATGGTGAAGGTCGGTGTGAA, R: GC CGTGAGTGGAGTCATACT)). PCR conditions were optimized to ensure the amplification of a single product was captured in the log phase of the reaction.
Miscellaneous
Elemental analyses, total protein quantitation and enzyme activity assays were performed as described in detail elsewhere (33) . Where applicable, data were presented as the mean 6 standard error of the mean, and significant differences between experimental groups were detected using a two-sample t-test assuming unequal variance. * denotes P < 0.05, ** denotes P < 0.01, *** denotes P < 0.001 and NS denotes not significant.
Supplementary Material
Supplementary Material is available at HMG online.
